Intelligent Intraocular Physiological Sensor System

A novel system integrating an intraocular physiological sensor with artificial intelligence, IoT, blockchain, and other technologies to provide real-time, personalized monitoring and treatment of glaucoma and other eye diseases.

The original patent disclosed an intraocular physiological sensor for measuring intraocular pressure. However, it had limitations in terms of data analysis, security, and real-time monitoring. The new inventive concept addresses these limitations by combining the sensor with AI, IoT, blockchain, and other technologies to provide a more comprehensive and effective system for glaucoma diagnosis and treatment.

The system comprises an intraocular physiological sensor, an AI module, a blockchain-based data storage module, and an IoT-enabled device. The sensor captures absolute intraocular pressure measurements, which are then transmitted to the AI module for analysis. The AI module uses machine learning algorithms to detect early signs of glaucoma and provide personalized treatment recommendations. The blockchain-based data storage module ensures secure storage and sharing of patient data. The IoT-enabled device enables real-time monitoring and alerts patients and healthcare providers. Additionally, the system can integrate with cloud-based data analytics platforms and mobile applications to provide a comprehensive monitoring and treatment system.

The new claims introduce the integration of AI, IoT, blockchain, and other technologies with the intraocular physiological sensor, which is not disclosed in the original patent. The inventive step lies in the synergistic combination of these technologies to provide a more effective and comprehensive system for glaucoma diagnosis and treatment.

Alternative embodiments of the system could include the use of different AI algorithms, integration with other medical devices, or the use of different blockchain platforms. Variations could include the development of specialized sensors for specific eye diseases or the integration of the system with electronic health records.

The intelligent intraocular physiological sensor system has significant commercial potential in the ophthalmology and healthcare industries. It can be marketed as a comprehensive monitoring and treatment system for glaucoma and other eye diseases, providing real-time data and personalized treatment recommendations. The system's potential market includes ophthalmology clinics, hospitals, and healthcare providers.